Celery seed has been used medicinally since antiquity, referenced in ancient Egyptian and Greek texts, valued both as a culinary spice and a traditional remedy for joint pain, gout, and fluid retention. Celery seed's active compound, 3-n-butylphthalide (3nB), was specifically identified by researchers at the University of Chicago Medical Center as the component likely responsible for celery's traditional blood-pressure-lowering reputation.
Celery seed's modern research profile splits between blood pressure and gout — both traditional claims genuinely being investigated with real human trials, though the depth of that evidence remains modest.
Celery seed has one genuinely notable recent human clinical trial: a 2025 randomized study in people with metabolic syndrome found celery seed administration significantly reduced systolic blood pressure, diastolic blood pressure, triglycerides, VLDL cholesterol, and uric acid levels — a real, multi-marker positive human trial result, encouraging for both the blood pressure and gout-related traditional claims.
The honest limitation: this remains largely a single-trial finding rather than an established, replicated evidence base. A consumer drug reference source states directly that "clinical studies are lacking to support a place in therapy," and a comprehensive pharmacological review found "the majority of existing relevant studies have been conducted in vitro, resulting in inadequate strength of evidence." Given one genuinely positive recent human trial but an overall literature still dominated by animal and laboratory research, "Limited" is the honest rating.
Whole or ground seeds used as a culinary spice; also prepared as tea, tincture, or standardized extract capsules.